HALAL Certification Obtained for
Tauri-Gum™ Brand (Etimad)
A HALAL
Certified Product Means that the
Product is Permissible or Acceptable in Accordance with
Islamic Law
NEW YORK, NY -- August 31, 2020 -- InvestorsHub NewsWire --
Tauriga Sciences, Inc. (OTCQB:
TAUG) (“Tauriga” or the “Company”), a revenue generating,
diversified life sciences company, with a proprietary line of
functional “supplement” chewing gums (Flavors: Pomegranate, Blood
Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as
two ongoing Biotechnology initiatives, today announced that it has
obtained HALAL Certification for the entirety of its flagship brand
Tauri-Gum™. A HALAL Certification is a guarantee that the products
comply with the Islamic dietary requirements or Islamic lifestyle.
The primary reason for Halal Certification is to serve the national
and international Muslim communities in meeting their religious
compliance.
With a global consumer base of about 1.9 billion Muslims across
112 countries, the Halal market size is estimated to be Tens of
Billions of US Dollars. Today, the three largest markets for HALAL
products are: The United States, Southeast Asia, and the Middle
East. These areas contain more than 400 million Muslim consumers.
Over the past decade, there has been a sharp increase in demand for
HALAL Certified products.
The Company’s HALAL Certification is under the supervision of:
Etimad Halal Certification (https://www.etimadhalal.com).
The Company’s flagship brand Tauri-Gum™ is also Kosher
Certified, under the supervision of Star-K (https://www.star-k.org)
Tauriga’s CEO Seth M. Shaw expressed, “The Company’s mission has
always been to develop outstanding products that are inclusive to
all demographics. This is an important certification as it
coincides with the upcoming national launch of our flagship brand
Tauri-Gum™. In addition, this HALAL certification opens new
international markets – specifically, the Middle East.”
ABOUT TAURIGA SCIENCES, INC.
Tauriga Sciences, Inc. (TAUG)
is a revenue generating, diversified life sciences company, engaged
in several major business activities and initiatives. The company
manufactures and distributes several proprietary retail products
and product lines, mainly focused on the Cannabidiol (“CBD”) and
Cannabigerol (“CBG”) Edibles market segment. The main product line,
branded as Tauri-Gum™, consists of a proprietary supplement chewing
gum that is both Kosher certified and Vegan formulated (CBD Infused
Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate) & (CBG
Infused Tauri-Gum™ Flavor: Peach-Lemon). The Company’s
commercialization strategy consists of a broad array of retail
customers, distributors, and a fast-growing E-Commerce business
segment (E-Commerce website: www.taurigum.com). Please visit our
corporate website, for additional information, as well as
inquiries, at http://www.tauriga.com.
Complementary to the Company’s retail business, are its two
ongoing biotechnology initiatives. The first one relates to
the development of a Pharmaceutical grade version of Tauri-Gum™,
for nausea regulation (specifically designed to help patients that
are subjected to ongoing chemotherapy treatment). On March 18,
2020, the Company announced that it filed a provisional U.S. patent
application covering its pharmaceutical grade version of
Tauri-Gum™. The Patent, filed with the U.S.P.T.O. is Titled
“MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS
OF TREATMENT”. The second one relates to a collaboration agreement
with Aegea Biotechnologies Inc. for the co-development of a rapid,
multiplexed, Novel Coronavirus (COVID-19) test with superior
sensitivity and selectivity.
The Company is headquartered in New York City and operates a
regional office in Barcelona, Spain. In addition, the Company
operates a full time E-Commerce fulfillment center located in
LaGrangeville, New York.
DISCLAIMER -- Forward-Looking Statements
This press release contains certain “forward-looking statements”
as defined by the Private Securities Litigation Reform Act of 1995
which represent management’s beliefs and assumptions concerning
future events. These forward-looking statements are often indicated
by using words such as “may,” “will,” “expects,” “anticipates,”
believes, “hopes,” “believes,” or plans, and may include statements
regarding corporate objectives as well as the attainment of certain
corporate goals and milestones. Forward-looking statements are
based on present circumstances and on management’s present beliefs
with respect to events that have not occurred, that may not occur,
or that may occur with different consequences or timing than those
now assumed or anticipated. Actual results may differ materially
from those expressed in forward-looking statements due to known and
unknown risks and uncertainties, such as are not guarantees of
general economic and business conditions, the ability to
successfully develop and market products, consumer and business
consumption habits, the ability to consummate successful
acquisition and licensing transactions, fluctuations in exchange
rates, and other factors over which Tauriga has little or no
control. Many of these risks and uncertainties are discussed in
greater detail in the “Risk Factors” section of Tauriga’s Form 10-K
and other filings made from time to time with the Securities and
Exchange Commission. Such forward-looking statements are made only
as of the date of this release, and Tauriga assumes no obligation
to update forward-looking statements to reflect subsequent events
or circumstances. You should not place undue reliance on these
forward-looking statements.
CONTACT:
Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY 10022
Chief Executive Officer
Mr. Seth M. Shaw
Email: sshaw@tauriga.com
Cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp. Website: www.tauriga.com
E-Commerce Website: www.taurigum.com
Public Relations:
See our partner here
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2023 to Apr 2024